Articles

Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols

Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy
Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy
St. Anna Kinderspital and Children’s Cancer Research Institute, Vienna, Austria
CLIP, Department of Pediatric Hematology and Oncology, 2ndFaculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
CLIP, Department of Pediatric Hematology and Oncology, 2ndFaculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy
Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy
Molecular Diagnostics, Children’s Cancer Institute, University of NSW, Sydney, NSW, Australia
Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Israel
Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Israel
Pediatrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
Department of Pediatric Hematology and Oncology, Scientific Institute for Research and Healthcare (IRCCS) Childrens' Hospital Bambino Gesù, Sapienza, University of Rome, Rome, Italy
IIGM Torino and Pediatric Hemato-Oncology, SDB Departiment, University of Padova, Padova, Italy
IIGM Torino and Pediatric Hemato-Oncology, SDB Departiment, University of Padova, Padova, Italy
Department of Human Genetics, Medical School Hannover, Hannover, Germany
Department of Human Genetics, Medical School Hannover, Hannover, Germany
Department of Human Genetics, Medical School Hannover, Hannover, Germany
Department of Human Genetics, Medical School Hannover, Hannover, Germany
Department of Human Genetics, Medical School Hannover, Hannover, Germany
St. Anna Kinderspital and Children’s Cancer Research Institute, Vienna, Austria
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
Women’s and Children’s Hospital, SA Pathology, University of Adelaide, Adelaide, Australia
Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany
St. Anna Kinderspital and Children’s Cancer Research Institute, Vienna, Austria
University Children’s Hospital Zurich, Zurich, Switzerland
Pediatric Hematology-Oncology Department, Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
CLIP, Department of Pediatric Hematology and Oncology, 2ndFaculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy
Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/S.Gerardo Hospital, Monza, Italy
Vol. 105 No. 7 (2020): July, 2020 https://doi.org/10.3324/haematol.2019.231720